Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Questcor continues lower as FDA says reviewing Acthar lab test results
The Fly on the Wall
Friday, February 28, 2014 - 11:58am
tags:
Questcor Pharmaceuticals, FDA, Acthar
Generic-Drug Failures Spur Concern as FDA Steps Up Action
Bloomberg
Friday, February 28, 2014 - 11:56am
tags:
generics, FDA
Small Is Beautiful? Not Without Biotech
Barron's
Friday, February 28, 2014 - 11:54am
tags:
biotech, Intercept Pharma
Merck's NOXAFIL gets positive opinion from CHMP
Yahoo/Fly on the Wall
Friday, February 28, 2014 - 11:50am
tags:
Merck, CHMP, Noxafil, Europe
Ligand says partner GSK submits application for Promacta
Yahoo/Fly on the Wall
Friday, February 28, 2014 - 11:48am
tags:
Ligand Pharmaceuticals, GSK, Promacta
Auxilium Q4 Beats Estimates, But Guidance Cautious
Investors.com
Friday, February 28, 2014 - 11:47am
tags:
earnings, Auxilium
Losses widen, but investors heartened by Clovis drug results
Markewatch
Friday, February 28, 2014 - 11:42am
tags:
Clovis Oncology, earnings, CO-1686
Bluebird Bio May Turn Dreams Into Reality
Seeking Alpha
Friday, February 28, 2014 - 10:33am
tags:
Bluebird Bio, gene therapy
Roche, Discuva enter deal to develop therapies against multi-drug resistant bacteria
First Word Pharma
Friday, February 28, 2014 - 10:30am
tags:
Roche, Discuva, antibiotic resistance, drug discovery, R&D
Illumina DNA Screen for Down Syndrome Found More Accurate
Bloomberg
Friday, February 28, 2014 - 8:44am
tags:
Illumina, Downs Syndrome, diagnostics
GSK trims Witty's bonus in face of China probe
Fierce Pharma
Friday, February 28, 2014 - 8:41am
tags:
China, GSK, Andrew Witty, executive pay
[video]Another Day, Another Big Pharma Breakup
Motley Fool
Friday, February 28, 2014 - 8:37am
tags:
Merck, consumer health, Bristol-Myers Squibb, Procter & Gamble, Novartis
Bayer Raises Drug Sales Forecast as Quarterly Profit Lags
Bloomberg
Friday, February 28, 2014 - 8:30am
tags:
Bayer, guidance, earnings
Arena's Belviq Sales To Hit $150 Million In 2014?
Seeking Alpha
Friday, February 28, 2014 - 8:29am
tags:
Belviq, obesity, Arena Pharmaceuticals, Eisai
Amarin Sues FDA Over Exclusivity for Fish Oil Pill
Bloomberg
Friday, February 28, 2014 - 8:26am
tags:
Amarin, FDA, Vascepa, exclusivity
Med tech industry backs a tax code reform that would repeal device tax
Fierce Medical Devices
Thursday, February 27, 2014 - 5:19pm
tags:
device tax, devices, Affordable Care Act
Radius Health looks to catch the IPO wave with $86M pitch
Fierce Biotech
Thursday, February 27, 2014 - 5:14pm
tags:
Radius Health, IPOs, osteoporosis
Drug firms argue against $1.2B Arkansas judgment
Yahoo/AP
Thursday, February 27, 2014 - 5:07pm
tags:
Arkansas, antipsychotics, JNJ, Janssen, Risperdal
The Vaccine Prevnar 13 And Its Competitor: Pfizer Vs. Merck
Seeking Alpha
Thursday, February 27, 2014 - 5:02pm
tags:
vaccines, Prevnar 13, Pfizer, Merck, Pneumovax
3 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Thursday, February 27, 2014 - 5:00pm
tags:
Intercept Pharma, Amgen, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.